)
Edge12 Jun 2026
Set in Stone: The Story of Richemont
From a South African tobacco company to Cartier, a deep dive into how Richemont built one of the world's leading hard luxury empires.
Neumora Therapeutics
Neumora Therapeutics (NMRA) investor relations material
Neumora Therapeutics Investor presentation summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Investor presentation summary17 Jun, 2026
Mission and leadership
Focus on developing next-generation, brain-penetrant therapies to improve outcomes and quality of life for patients with neurological and psychiatric disorders.
Led by experienced executives and board members with backgrounds in major pharmaceutical and biotech companies.
Strategic focus and market opportunity
Targeting large unmet needs in neurodegenerative, neuropsychiatric, and metabolic diseases, including Alzheimer's, Parkinson's, schizophrenia, and obesity.
Addressing markets with millions of affected patients and significant growth potential, such as Alzheimer's agitation and obesity.
Pipeline and clinical programs
Advancing three core franchises: neurodegenerative (NMRA-511, NMRA-GCASE, NMRA-CK18), neuropsychiatric (NMRA-898), and metabolic (NMRA-215).
Multiple clinical milestones expected in 2026, including Phase 2 initiation for NMRA-511, Phase 1 data for NMRA-898, and clinical entry for NMRA-215.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Neumora Therapeutics
- Directors re-elected, auditor ratified, and annual executive pay votes approved.NMRA
AGM 202630 May 2026 - Navacaprant, NMRA-511, NMRA-215, and NMRA-898 advance with key data readouts and clinical milestones ahead.NMRARBC Capital Markets Global Healthcare Conference 202622 May 2026
- Net loss narrowed to $53.5M as cash runway extends into Q3 2027 and pipeline advances.NMRAQ1 20267 May 2026
- Virtual meeting to elect directors, ratify auditor, and vote on executive pay and frequency.NMRAProxy filing17 Apr 2026
- Annual meeting to vote on directors, auditor, executive pay, and key governance matters.NMRAProxy filing17 Apr 2026
- Major data for MDD and Alzheimer's agitation expected, with strong financial runway and pipeline progress.NMRA25th Annual Needham Virtual Healthcare Conference13 Apr 2026
- Pipeline advanced with strong cash position and key 2026 clinical milestones ahead.NMRAQ4 202530 Mar 2026
- Advancing novel therapies for brain and metabolic disorders with key milestones expected by 2027.NMRACorporate presentation30 Mar 2026
- NMRA-511 shows strong efficacy in Alzheimer's agitation; pipeline and funding support robust growth.NMRAGuggenheim Securities Emerging Outlook: Biotech Summit 202612 Feb 2026
Next Neumora Therapeutics earnings date
Q2 20265 Aug, 2026
Neumora Therapeutics
Next Neumora Therapeutics earnings date
Q2 20265 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage